The agreement between NEXT Oncology and Quirónsalud Group established a research program that provides the highest possible number of early phase clinical trials in Spain, with locations in Barcelona and Madrid. It also offers quality, safety, and specialized care to patients enrolled in the trials, while thereby ensuring top-notch scientific rigor and creating opportunities to translate research findings to routine clinical practice.
Developing a new drug is a complex undertaking. Before a drug can be brought to market, there must be proof that it is safe, that it has an impact on the disease, and that this impact offers patients added benefits over existing treatments. Early phase clinical trials therefore allow patients to be treated with novel drugs that are potentially more effective and better tolerated.
If you are interested in participating in trials at NEXT Oncology, please contact us to learn more.
Plaza Alfons Comin 5 – 9 08023 Barcelona,
Spain
Phone: Dial 011 +34 932-381-661
Open Monday-Friday 8:00 AM to 5:00 PM
